XALOX RTU oxaliplatin 200mg/40mL concentrated solution for injection vial

Active ingredient:

oxaliplatin, Quantity: 200 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Oxaliplatin

Pharmaceutical form:

Injection, concentrated

Composition:

Excipient Ingredients: lactose monohydrate; water for injections

Administration route:

Intravenous Infusion

Units in package:

1 vial

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: ,? Adjuvant treatment of stage III (Duke?s C) colon cancer after complete resection of ,the primary tumour ,? Treatment of advanced colorectal cancer

Product summary:

Visual Identification: Clear, colourless to slightly yellow solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2011-12-12